IMO good punt here at $57 million mcap with ~11million cash ( guesstimate) . EV of $46 million.
Human trial news expected in first half of 2022,
I don’t understand the selling pressure. Low volume but consistent. Is it just the impatient giving up on the company and cutting losses in most cases? Didn’t notice any significant changes in top 20 holdings in recent times. Interested to hear your views.
